Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 July 2007

Thorax. Published Online First: 27 February 2007. doi:10.1136/thx.2006.072892
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society.

Papers

Lung Cancer Diagnosis by the Analysis of Exhaled Breath with a Colorimetric Sensor Array

Peter J Mazzone 1*, Jeffrey Hammel 1, Raed Dweik 1, Jie Na 1, Carmen Czich 1, Daniel Laskowski 1 and Tarek Mekhail 1

1 Cleveland Clinic, United States

* To whom correspondence should be addressed. E-mail: mazzonp{at}ccf.org.

Accepted 3 January 2007


Abstract

Background: The pattern of volatile organic compounds in the exhaled breath of lung cancer patients may be unique. Novel sensor systems that detect patterns of volatiles have been developed. One of these sensor systems, a colorimetric sensor array, has 36 spots composed of different chemically sensitive compounds impregnated on a disposable cartridge. The colors of these spots change based on the chemicals they come in contact with. In this proof of principle study, we assess the ability of this sensor system to detect a pattern of volatiles unique to lung cancer.

Methods: Individuals with lung cancer, other lung diseases, and healthy controls performed tidal breathing of room air for 12 minutes while exhaling into a device designed to draw their breath across a colorimetric sensor array. The color changes that occurred for each individual were converted into a numerical vector. The vectors were analyzed statistically, using a random forests technique, to determine if lung cancer could be predicted from the sensor responses.

Results: 143 individuals participated in the study. 49 with non-small cell lung cancer, 18 COPD, 15 IPF, 20 PAH, 20 sarcoid, and 21 controls. A prediction model was developed using observations from 70% of the subjects. This model was able to predict the presence of lung cancer in the remaining 30% of the subjects with a sensitivity of 73.3% and specificity of 72.4% (p=0.01).

Conclusions: The unique chemical signature of the breath of lung cancer patients is able to be detected with moderate accuracy by a colorimetric sensor array.

Keywords: Breath analysis, Colorimetric sensor array, Diagnosis, Lung cancer, Volatile organic compounds


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Westhoff, M, Litterst, P, Freitag, L, Urfer, W, Bader, S, Baumbach, J-I (2009). Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64: 744-748 [Abstract] [Full Text]  
  • Horvath, I., Lazar, Z., Gyulai, N., Kollai, M., Losonczy, G. (2009). Exhaled biomarkers in lung cancer. Eur Respir J 34: 261-275 [Abstract] [Full Text]  
  • Ghosal, R, Kloer, P, Lewis, K E (2009). A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad. Med. J. 85: 358-363 [Abstract] [Full Text]  
  • Dubey, S., Powell, C. A. (2008). Update in Lung Cancer 2007. Am. J. Respir. Crit. Care Med. 177: 941-946 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs